Aiding development of a new anti-cancer drug
May 1st, 2008
CSIRO has entered into an agreement with Adelaide-based biotech company, Oncaidia Ltd, to make the company’s new anti-cancer drug, Apomab(R), suitable for human trials.
Oncaidia’s Managing Director, Keith Smith, says Apomab has the potential to aid in the management of a number of human cancers that are currently difficult to treat – including prostate cancer and lung cancer.